Literature DB >> 35221288

Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.

Ruizhi Gu1, Alina Liang1, Grace Liao1, Isabelle To1, Amina Shehu1, Xiaochao Ma2.   

Abstract

Drug-induced liver injury (DILI) remains one of the major concerns for healthcare providers and patients. Unfortunately, it is difficult to predict and prevent DILI in the clinic because detailed mechanisms of DILI are largely unknown. Many risk factors have been identified for both "intrinsic" and "idiosyncratic" DILI, suggesting that cofactors are an important aspect in understanding DILI. This review outlines the cofactors that potentiate DILI and categorizes them into two types: (1) the specific cofactors that target metabolic enzymes, transporters, antioxidation defense, immune response, and liver regeneration; and (2) the general cofactors that include inflammation, age, gender, comorbidity, gut microbiota, and lifestyle. The underlying mechanisms by which cofactors potentiate DILI are also discussed. SIGNIFICANCE STATEMENT: This review summarizes the risk factors for DILI, which can be used to predict and prevent DILI in the clinic. This work also highlights the gaps in the DILI field and provides future perspectives on the roles of cofactors in DILI.
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2022        PMID: 35221288      PMCID: PMC9132098          DOI: 10.1124/dmd.121.000457

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.579


  190 in total

1.  The Opportunities of Metabolomics in Drug Safety Evaluation.

Authors:  Pengcheng Wang; Amina I Shehu; Xiaochao Ma
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

2.  Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.

Authors:  Francis F Fountain; Elizabeth Tolley; Cary R Chrisman; Timothy H Self
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

3.  The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.

Authors:  Camila Zaverucha-do-Valle; Sérgio P Monteiro; Kênia B El-Jaick; Leonardo A Rosadas; Marli J M Costa; Marcel S B Quintana; Liane de Castro
Journal:  Tuberculosis (Edinb)       Date:  2014-04-01       Impact factor: 3.131

4.  Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

Authors:  C Funk; C Ponelle; G Scheuermann; M Pantze
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

5.  Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2009-04-07       Impact factor: 4.030

6.  Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

Authors:  A Quémard; C Lacave; G Lanéelle
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

Authors:  Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

8.  Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

Authors:  M Isabel Lucena; Raúl J Andrade; Neil Kaplowitz; Miren García-Cortes; M Carmen Fernández; Manuel Romero-Gomez; Miguel Bruguera; Hacibe Hallal; Mercedes Robles-Diaz; Jose F Rodriguez-González; Jose Maria Navarro; Javier Salmeron; Pedro Martinez-Odriozola; Ramón Pérez-Alvarez; Yolanda Borraz; Ramón Hidalgo
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

9.  The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.

Authors:  J Christopher Gorski; Shiew-Mei Huang; Amar Pinto; Mitchell A Hamman; Janna K Hilligoss; Narjis A Zaheer; Mehul Desai; Margaret Miller; Stephen D Hall
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

Review 10.  Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

Authors:  Alexander D Roth; Moo-Yeal Lee
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.